The role of progesterone signaling in the pathogenesis of uterine leiomyoma
about
Mifepristone for uterine fibroidsProceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendationsGenome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells.Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence.1,25-dihydroxyvitamin D3 regulates expression of sex steroid receptors in human uterine fibroid cells.Use of depot medroxyprogesterone acetate and prevalent leiomyoma in young African American women.Stro-1/CD44 as putative human myometrial and fibroid stem cell markers.Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.Immunoexpression of Steroid Hormone Receptors and Proliferation Markers in Uterine Leiomyoma and Normal Myometrial Tissues from the Miniature Pig, Sus scrofa.Expression profiling of nuclear receptors identifies key roles of NR4A subfamily in uterine fibroids.Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction.MK-2206, an AKT inhibitor, promotes caspase-independent cell death and inhibits leiomyoma growth.Effect of Isopropanolic Cimicifuga racemosa Extract on Uterine Fibroids in Comparison with Tibolone among Patients of a Recent Randomized, Double Blind, Parallel-Controlled Study in Chinese Women with Menopausal Symptoms.Uterine fibroid management: from the present to the future.Safety of treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate.Quantitative proteome profiling of human myoma and myometrium tissue reveals kinase expression signatures with potential for therapeutic intervention.Human Chorionic Gonadotrophin as a Possible Mediator of Leiomyoma Growth during Pregnancy: Molecular Mechanisms.Myomas and Adenomyosis: Impact on Reproductive Outcome.Progesterone Receptor Isoforms, Nuclear Corepressor-1 and Steroid Receptor Coactivator-1 and B-Cell Lymphoma 2 and Akt and Akt Phosphorylation Status in Uterine Myomas after Ulipristal Acetate Treatment: A Systematic Immunohistochemical Evaluation.The Rising Phoenix-Progesterone as the Main Target of the Medical Therapy for Leiomyoma.Comparative systems genetics view of endometriosis and uterine leiomyoma: Two sides of the same coin?Efficacy of ormeloxifene versus oral contraceptive in the management of abnormal uterine bleeding due to uterine leiomyoma.Pathobiology of myomatosis uteri: the underlying knowledge to support our clinical practice.Fertility impairment associated with uterine fibroids – a review of literature.Current medical treatment of uterine fibroids.Dysregulated chaperones associated with cell proliferation and negative apoptosis regulation in the uterine leiomyoma.Vitamin D and Uterine Fibroids-Review of the Literature and Novel ConceptsClinical and Economic Management of Uterine Fibroids: The Point of View of a Decision Makers Board
P2860
Q24201506-913F8F62-854B-4DFA-A443-A84995FAA57FQ24567733-03255B64-F1EA-494F-8BAC-20508BCED504Q34137268-4F53F40E-49AD-475B-939E-66B8AEC127A8Q34321877-F979B26C-5EBE-4DAA-8417-EEE3781CD924Q35240186-05005DF6-44ED-4FE0-927E-80759B9E1E4CQ35441965-AC376DE8-9E01-421F-9F7E-21EE45044479Q35662059-34D229A3-1BF3-436B-8633-A1F6CC814984Q35812468-7E564D8D-1CE0-4C84-A4A6-B4D3F12AE0CEQ35944399-706A6691-2DBF-43E5-B465-BBB75B88490BQ36723027-680413C9-8271-41F0-BC95-DEA68596BEFEQ36789291-D4167C2D-A9EF-4CAA-80F5-0EA93AED6426Q37218723-AFCDB1D3-23F8-46D6-87E2-214F7983C8D2Q37240206-1B0EAA22-0A86-4AE3-AB74-9A59BB51E998Q37639764-3F3A0A7E-E854-4EF4-AAF5-E40D97A10E66Q38837038-103160F6-EC5D-4580-A13C-F397B9FAAADEQ38980489-D52E0528-553C-434B-8B66-142C4293A374Q39111024-4380D2EC-0384-432D-8488-127BC2E623E1Q41660259-FCC635A4-30FE-4200-B7C6-FA99031F0306Q47131910-73AE350C-1F02-4127-A8FC-AD82EA772AC8Q47307932-C57E248A-711D-4A3D-A2C9-ABEBD636610DQ47561375-3FFDB17F-2B9B-4E6E-83CC-5B8C2C1C86D3Q47589569-BD73E0E9-5A10-40F9-A642-86B1288736B2Q47682996-5E3B4DA2-5455-4F2F-ABAF-BBB443CF9E6CQ48137294-A42D3A9D-F593-4611-AC6F-9F809025151EQ50282951-E5644C57-58F0-493F-972F-B6367DB80EB4Q51736809-9145D561-92CE-4E74-8A56-447C1440B438Q55390643-97D0123B-B292-489B-8E11-D4199C9AB68DQ57176044-4E8EBF19-EC68-4D64-8CF4-933785C76390Q57600559-7BACD395-A82B-42B2-8CDF-C46E9345F784
P2860
The role of progesterone signaling in the pathogenesis of uterine leiomyoma
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The role of progesterone signaling in the pathogenesis of uterine leiomyoma
@ast
The role of progesterone signaling in the pathogenesis of uterine leiomyoma
@en
type
label
The role of progesterone signaling in the pathogenesis of uterine leiomyoma
@ast
The role of progesterone signaling in the pathogenesis of uterine leiomyoma
@en
prefLabel
The role of progesterone signaling in the pathogenesis of uterine leiomyoma
@ast
The role of progesterone signaling in the pathogenesis of uterine leiomyoma
@en
P2860
P1476
The role of progesterone signaling in the pathogenesis of uterine leiomyoma
@en
P2093
Elizabeth C Sefton
J Julie Kim
P2860
P304
P356
10.1016/J.MCE.2011.05.044
P577
2011-06-06T00:00:00Z